PBMs Under Fire Again, But Despite Bipartisan Pressure Reforms May Be Elusive
As Lina Khan, chair of the Federal Trade Commission, ends her tenure this week the FTC posted a second report in six months ...
Trump has promised to ‘knock out’ pharmacy benefit managers. How the drug middlemen became a $557 billion industry that its customers love to hate
The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.
Fierce Healthcare1d
NCPA: Independent pharmacies weigh stocking drugs under Medicare price negotiation
The National Community Pharmacists Association (NPCA) is warning the feds that independent pharmacists are likely to face ...
Opinion
Congress Can't Wait—Reform Pharmacy Benefit Managers and Deliver Lower-Cost Drugs for Patients | Opinion
The PBM system intentionally blocks lower-cost, FDA-approved biosimilars from being available to patients. Biosimilars are the commonsense, bipartisan solution to out-of-control prescription drug ...
MedCity News13d
Healthcare Leaders Support FTC’s Second Report on PBMs, While PBMs Criticize Findings
On Tuesday, the Federal Trade Commission released its second interim staff report on prescription drug middlemen. The report ...
STAT13d
Will PBM reform save pharmacies from closing?
Mattingly is an associate professor and vice chair of research in the Department of Pharmacotherapy at the University of Utah ...
RealClearMarkets6d
Diagnosing the Problem With PBMs' Incentives
Pharmacy Benefit Managers (PBM) sit in the center of our prescription drug system, coordinating between insurance companies, ...
STAT13d
Pharmalittle: We’re reading about FTC criticizing PBMs, an NIH policy on access to medicines, and more
The FDC released a second highly critical report of PBMs, which may provide further impetus for legislative action to curb ...
Drug Store News4d
NACDS explains PBMs in latest video
The National Association of Chain Drug Stores released a video that explains how PBMs operate and how states and Congress are ...
Becker's Hospital Review4d
PBMs hit with $10 million verdict in antitrust case
Arbitrator Stuart Widman found that Prime violated federal and state antitrust laws by engaging in price-fixing agreements with Express Scripts, another major PBM, according to a Jan. 23 news release ...
penncapital-star2dOpinion
Inflated drug costs hurt Pennsylvanians
The report shows that PBMs made over $7.3 billion in extra profits from dispensing specialty generic drugs during the study ...
News96d
OKC sues PBMs and insulin manufacturers over price gouging
City attorneys allege major Pharmacy Benefit Managers (PBMs) and insulin manufacturers are conspiring to artificially inflate ...